Join us on Tuesday, May 25th at 2:00 PM Eastern Time U.S.
Please register by Monday, May 24th by 8:00 PM Eastern Time U.S.
Our speakers are:
Dr. Eric Nguyen from NEI/NIH - "3D Bioprinted Model of Outer Blood-retinal Barrier to investigate AMD Progression and Treatment"
Dr. Budd Tucker from the University of Iowa - "Treating Heritable Blindness"
Dr. Shawn Owen from the University of Utah
Dr. Hana El-Samad from the University of California, San Francisco
Conference Dates: July 10-13, 2022
Conference Location: Sheraton Centre Toronto Hotel Conference
Co-Chairs: Prof. Alison McGuigan, Prof. Penney Gilbert and Prof. Carlos Aguilar
UPCOMING TWIGs WEBINAR SERIES DATES:
The webinars are a membership benefit offered to our members. If you wish to attend a TERMIS webinar and would like to become a member, please complete the membership application.
The webinars begin at 11:00 AM PDT / 2:00 PM EDT unless indicated otherwise. The webinars are scheduled for one hour.
Closing video: https://youtu.be/-664W8YjYsU (slides attached)
Staying connected in the tissue engineering community
VIRTUAL WEBINAR SERIES
The TERMIS-AM Membership Committee has formulated a list of webinars being conducted in the region.
Communication and connectivity within the tissue engineering community are critical objectives of TERMIS. Staying connected and up to date with research in the field is more important now than ever before. In addition to bringing you TERMIS chapter meetings, World Congress, and TWIG seminars, we have curated a list of recurring virtual webinar series from other institutions in the region in diverse topics relevant to tissue engineering and regenerative medicine. If you are hosting a recurring virtual seminar series that you would like to add to the list, please contact matthew.wolf@nih.gov.
|
||
|
|
The objectives of the TWIGs are:
AIMBE's Mission
The American Institute for Medical and Biological Engineering (AIMBE) is the authoritative voice and advocate for the value of medical and biological engineering to society. It is an organization of leaders in medical and biological engineering, consisting of academic, industrial, professional society councils and elected fellows. aimbe.org
AIMBE Student Policy Resources
AIMBE has launched Student Policy Resources students and trainees interested in getting active in science policy. AIMBE has put together a set of materials geared toward graduate students seeking to:
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stake-holder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, DC to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 150 members and is the leading global advocacy organization in this field. To learn more about ARM or to become a member, visit www.alliancerm.org.
STEM CELL MEETING ON THE MESA
MORE INFO & REGISTRATION
http://stemcellmeetingonthemesa.com
ABOUT THE OVERALL MEETING
The Stem Cell Meeting on the Mesa is a three-day conference bringing together senior executives and top decision-makers in the regenerative medicine and advanced therapies industry with the scientific community to advance cutting-edge research into cures. The meeting features a nationally recognized Scientific Symposium, attended by leading researchers and clinical experts from around the globe, in conjunction with the industry's premier annual Partnering Forum, the first and only event of its kind dedicated solely to facilitating connections in this sector. Combined, these meetings attract nearly 800 attendees, fostering key partnerships through more than 500 one-on-one meetings while highlighting the significant clinical and commercial progress in the field over the past year.
